Frits Rosendaal
Frits Rosendaal
hoogleraar Klinische Epidemiologie, Leiden University Medical Center
Geverifieerd e-mailadres voor
Geciteerd door
Geciteerd door
Heart disease and stroke statistics—2012 update: a report from the American Heart Association
Writing Group Members, VL Roger, AS Go, DM Lloyd-Jones, EJ Benjamin, ...
Circulation 125 (1), e2-e220, 2012
Heart disease and stroke statistics-2003 update
American Heart Association
http://www. americanheart. org/downloadable/heart …, 2002
Mutation in blood coagulation factor V associated with resistance to activated protein C
RM Bertina, BPC Koeleman, T Koster, FR Rosendaal, RJ Dirven, ...
Nature 369 (6475), 64-67, 1994
A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
SR Poort, FR Rosendaal, PH Reitsma, RM Bertina
Malignancies, prothrombotic mutations, and the risk of venous thrombosis
JW Blom, CJM Doggen, S Osanto, FR Rosendaal
Jama 293 (6), 715-722, 2005
Venous thrombosis: a multicausal disease
FR Rosendaal
The Lancet 353 (9159), 1167-1173, 1999
A method to determine the optimal intensity of oral anticoagulant therapy
FR Rosendaal, SC Cannegieter, FJM Van der Meer, E Briet
Thrombosis and haemostasis 69 (03), 236-239, 1993
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease
H Schunkert, IR König, S Kathiresan, MP Reilly, TL Assimes, H Holm, ...
Nature genetics 43 (4), 333-338, 2011
Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study
T Koster, JP Vandenbroucke, FR Rosendaal, H De Ronde, E Briėt, ...
The Lancet 342 (8886-8887), 1503-1506, 1993
Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation
JP Vandenbroucke, T Koster, FR Rosendaal, E Briėt, PH Reitsma, ...
The Lancet 344 (8935), 1453-1457, 1994
Hyperhomocysteinemia as a risk factor for deep-vein thrombosis
M Den Heijer, T Koster, HJ Blom, GMJ Bos, E Briėt, PH Reitsma, ...
New England journal of medicine 334 (12), 759-762, 1996
Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis
T Koster, JP Vandenbroucke, FR Rosendaal, E Briėt, AD Blann
The Lancet 345 (8943), 152-155, 1995
Incidence and mortality of venous thrombosis: a population‐based study
IA Nęss, SC Christiansen, P Romundstad, SC Cannegieter, ...
Journal of thrombosis and haemostasis 5 (4), 692-699, 2007
High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)[see comments]
FR Rosendaal, T Koster, JP Vandenbroucke, PH Reitsma
The risk of myocardial infarction associated with antihypertensive drug therapies
BM Psaty, SR Heckbert, TD Koepsell, DS Siscovick, TE Raghunathan, ...
Jama 274 (8), 620-625, 1995
Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials
Homocysteine Lowering Trialists' Collaboration
Bmj 316 (7135), 894-898, 1998
Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses.
SC Cannegieter, FR Rosendaal, E Briet
Circulation 89 (2), 635-641, 1994
Optimal oral anticoagulant therapy in patients with mechanical heart valves
SC Cannegieter, FR Rosendaal, AR Wintzen, FJM Van der Meer, ...
New England Journal of Medicine 333 (1), 11-17, 1995
Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study
KM Musallam, HM Tamim, T Richards, DR Spahn, FR Rosendaal, ...
The Lancet 378 (9800), 1396-1407, 2011
Inherited thrombophilia: part 1
DA Lane, PM Mannucci, KA Bauer, RM Bertina, NP Bochkov, ...
Thrombosis and haemostasis 76 (5), 651-662, 1996
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20